Aug. 13, 2018 - Dallas, TX, - (GLOBE NEWSWIRE) — Nexeon MedSystems Inc (”Nexeon”) (OTCQB: NXNN), a neurostimulation medical device company,…
Nexeon MedSystems Announces Second Quarter 2018 Financial Results
Nexeon Receives “NXNN” Ticker Symbol from FINRA and Raises $1.165M
Aug. 9, 2018 - Dallas, TX - /PRNewswire/ — Nexeon MedSystems, Inc. (OTCQB:NXNN) announced it has received its ticker symbol from FINRA and will…
Nexeon MedSystems Announces First Quarter 2018 Financial Results
May 21, 2018 - Dallas, TX - (GLOBE NEWSWIRE) — Nexeon MedSystems Inc (”Nexeon”) (OTCQB:NXNN) a neurostimulation medical device company,…
Nexeon MedSystems Appoints Wes Dittmer, CPA to Board of Directors
DALLAS, April 25, 2018 (GLOBE NEWSWIRE) — Nexeon MedSystems Inc. (“Nexeon”) (OTCQB:NXNN) a neurostimulation medical device company, today announced the…
Nexeon MedSystems Announces Fourth Quarter and Full Year Results
DALLAS, April 05, 2018 (GLOBE NEWSWIRE) — Nexeon MedSystems Inc (”Nexeon”) (OTCQB:NXNN) a neurostimulation medical device company, announced today financial…
Taglich Brothers Initiates Nexeon Medsystems Inc.
NEW YORK, Jan. 16, 2018 (GLOBE NEWSWIRE) — Taglich Brothers, Inc. announces that it has initiated coverage of Nexeon Medsystems…
Nexeon’s neurotechnology in the fight against our aging bodies
We haven’t even come close to solving the problem of an aging population, so the tech sector is stepping in.…
Nexeon MedSystems Provides Shareholder Update
Company to Host Conference Call November 20, 2017 4pm CST DALLAS, Nov. 20, 2017 /PRNewswire/ — Nexeon MedSystems Inc. (OTCQB:…
Nexeon Begins Clinical Study with Newly Developed Non-Invasive Vagus Nerve Stimulator
Feasibility Study is First Phase of €3.4M BioWin Award LIEGE, Belgium, Oct. 25, 2017 /PRNewswire/ — Nexeon MedSystems Inc (OTCBB: NXNN)…
Nexeon MedSystems Goes Public, Receives Innovation Grants
Nexeon shares are trading over the counter as the company moves forward with advanced medical systems. As Nexeon MedSystems Inc.…